In an analysis of BMS' recent clinical history, Industry analysts at Trefis noted that two oncology drugs will be key revenue drivers for the company. Source: BioSpace

Astellas is pulling the trigger on an acquisition option from a partnership deal the two companies formed in 2013. Source: BioSpace

Mettler-Toledo will begin to issue pink slips in March to employees at an upstate New York manufacturing facility. Source: BioSpace

Migraine sufferers may find some new relief as Amgen unveiled results from a late-stage study that shows its Phase III drug Aimovig reduced monthly migraine attacks in half. Source: BioSpace

The company's head of Development, Joerg Moeller, is taking the reins of the company's new R&D program. Source: BioSpace

Big pharma stocks have been longtime favorites among investors for several reasons. Source: BioSpace

The round was co-led by Eight Roads Ventures and Cowen Healthcare Investments. Source: BioSpace

Genmab just received a $20M milestone payment from Janssen Biotech. Source: BioSpace

Sanofi's setback could open the door for rival drugmaker Takeda. Source: BioSpace

This financing brings the total capital raised this year to $65 million, including a $25 million Series A financing that was completed earlier this year. Source: BioSpace